Concepedia

Martin L. Koser

ML

Statistics

Publications

16

Citations

889

H-Index

15

Active since

2003

Affiliations

Thomas Jefferson University(Current)

Dicerna Pharmaceuticals (United States)

United States Military Academy

Centre for Biomedical Network Research on Rare Diseases

Martin L. Koser is an author at Thomas Jefferson University specializing in life sciences, infectious diseases, and molecular biology.

Publications per year

2003–2021

16

Publications

16

Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment

Marc Abrams, Martin L. Koser, Jessica Seitzer et al. · Molecular Therapy · 2009 · 208 citations · Full text

, , +17

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

Cheng-Jung Lai, Natalie W. Pursell, Jessica J. Gierut et al. · Molecular Therapy · 2018 · 106 citations · Full text

, , +13

Quantitative evaluation of siRNA delivery in vivo

Yi Pei, Paula J. Hancock, Hangchun Zhang et al. · RNA · 2010 · 83 citations · Full text

, , +17

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie W. Pursell et al. · Molecular Therapy · 2016 · 83 citations · Full text

, , +15

Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome

James P. McGettigan, Kristin Naper, Jan M. Orenstein et al. · Journal of Virology · 2003 · 67 citations · Full text

, , +17

1–5 of 16